Coalition Aims to Improve Supportive Cancer Care

Commentary
Video

Health care organizations have come together to form the Together for Supportive Cancer Care coalition to address gaps in supportive cancer care services.

Together for Supportive Cancer Care is a collaborative effort between health care organizations to enhance the quality and accessibility of supportive care for patients with cancer. Recognizing the insufficiency of current supportive care services, the coalition aims to improve the overall patient experience by addressing various aspects of care, including physical, psychological, social, and spiritual support.

Andrew T. Leitner, MD, chair in the Department of Supportive Care Medicine, associate clinical professor in the Department of Anesthesiology, and chief in the Division of Interventional Patin Management at City of Hope in Duarte, California, spoke with CancerNetwork® about this new initiative. By sharing best practices, conducting research, and advocating for policy changes, the coalition strives to create a more comprehensive and supportive care environment for patients with cancer and their families.

Transcript:

Together for Supportive Cancer Care came from a recognition that a number of health care organizations are working to advance a common goal and can do it better together. That common goal is the comprehensive support that patients navigating a serious illness—in this case, cancer—need, and the ways that the health care system currently meets those needs is insufficient for the scope and scale of those needs. How do member organizations come together to learn from one another, share best practices, conduct research, and move advocacy toward policy that helps the supportive care provision for patients and their loved ones [with] cancer?

One of the first things the coalition was primed to do was to define terms and the scope of the problem. To start, when we talk about supportive care, we talk broadly about the support of the patient with cancer and their family and community, but that specifically means a constellation of access to various clinical and community services and programs to help manage the various adverse effects of a cancer diagnosis. The coalition first and foremost was establishing a shared set of definitions of what we mean when we say supportive care in cancer or supportive cancer care. Some of the essential components of that include how we assess and manage physical symptoms, how we provide psychological and emotional support, and social and practical support. [Another focus is] a number of the specialty aspects of supportive care in cancer, such as spiritual care, end-of-life care, various rehabilitation services, and integrative therapies. How do we pull all of those together so that they’re well well-coordinated as the patient is navigating our complex health care system?

Recent Videos
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
Daniel Peters, MD, aims to reduce the toxicity associated with AML treatments while also improving therapeutic outcomes.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Related Content